A metabolic approach during normothermic regional perfusion in uncontrolled donors after circulatory death—A pilot study
Adult
Male
Brain Death
Adolescent
610
Pilot Projects
normothermic regional perfusion
03 medical and health sciences
Extracorporeal Membrane Oxygenation
0302 clinical medicine
metabolic
617
Humans
Prospective Studies
Aged
Retrospective Studies
transaminase
lactate
uncontrolled donors after circulatory death
Cold Ischemia
creatinine
Organ Preservation
Organ Transplantation
extracorporeal membrane oxygenation
Middle Aged
creatinine; extracorporeal membrane oxygenation; lactate; metabolic; normothermic regional perfusion; transaminases; uncontrolled donors after circulatory death
Tissue Donors
3. Good health
Perfusion
Creatinine
Tissue and Organ Harvesting
Female
Follow-Up Studies
DOI:
10.1111/ctr.13387
Publication Date:
2018-08-22T15:57:04Z
AUTHORS (11)
ABSTRACT
AbstractThe use of donation after circulatory death (DCD) has increased significantly to face the persistent mismatch between supply and demand of organs for transplantation. While controlled (c) DCDs have warm ischemic time (WIT) that can be estimated, the WIT is often inexact and extended in uncontrolled DCD (uDCD), making assessment of injury difficult. We aimed at investigating the effects of cold ischemia on potential donor organ damage in the course of nRP by assessing the dynamic variations of transaminases and creatinine values in 17 uDCD donors. In our series, lactate values did not show significant changes during the study period (P = 0.147). Creatinine values did not significantly changed while transaminases progressive increased throughout the study period, even if it was significant only for AST (P = 0.035). According to our data, nRP duration affects splanchnic organs, being the liver sensitive to hypoperfusion, and serial biochemical measurements could help in detecting organ functional status.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (19)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....